4-(Prop-2-yn-1-yloxy)piperidine hydrochloride, 98%, 250mg

(2-(Hydroxymethyl)-4-(trifluoromethyl)phenyl)boronic acid, 98%, 5g

2-(1,3-Benzothiazol-2-yl)propan-2-ol, 97%, 500mg

DBD-COCl [=4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling]>93.0%(T)100mg

3-amino-N-(3,4-dimethylphenyl)benzamide, 95.0%, 5g

4-(Trifluoromethyl)picolinonitrile, 95.0%, 25g

(R)-3-Hydroxymethyl-piperidine hydrochloride, 95.0%, 25g

3-NITRO-4-(TRIFLUOROMETHOXY)BENZONITRILE, 95.0%, 250mg

6-Propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one, 95.0%, 5g

3-Bromo-4-iodo-tert-butylbenzene, 97.0%, 100g

Pyridine-3-carboxamide oxime, 99.0%, 10g

(S)-2-(6-Bromobenzo[d][1,3]dioxol-5-yl)-N-(4-cyanophenyl)-1-(1-cyclohexylethyl)-1H-benzo[d]imidazole-5-carboxamide, 97%, 10mg

tert-Butyl(2-iodoethoxy)dimethylsilane, 95.0%, 1g